Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02773524
Title A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEII)
Acronym INTEGRATEIIa
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors Australasian Gastro-Intestinal Trials Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NZL | CAN | AUS


No variant requirements are available.